Immunotherapy for EGFR Mutated Lung Cancer
收藏Mendeley Data2026-04-18 收录
下载链接：
https://data.mendeley.com/datasets/3fjsc6y4n4
下载链接
链接失效反馈官方服务：
资源简介：
Patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations face poor outcomes after progression on tyrosine kinase inhibitors (TKIs). The efficacy of immune checkpoint inhibitors (ICIs) combined with chemotherapy in these patients remains uncertain. Therefore, we performed this meta-analysis.
创建时间：
2024-07-08
